Clinical Trial Update: Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the multi-antigen CMV-MVA Triplex Vaccine to reduce cytomegalovirus complications in CMV-seropositive patients undergoing donor hematop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• CMV-MVA Triplex Vaccine (CMV-MVA Triplex Vaccine)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-04-14